Indication

Reduction of elevated intraocular pressure (IOP) in adult patients with primary open-angle glaucoma or ocular hypertension (OHT) for whom monotherapy with a prostaglandin or netarsudil provides insufficient IOP reduction.

Medicine details

Medicine name:
netarsudil / latanoprost (Roclanda)
SMC ID:
SMC2720
Pharmaceutical company
Santen
BNF chapter
Eye
Submission type
Full
Publication due date:
TBC
SMC meeting date:
TBC
Patient group submission deadline:
02 December 2024